July 18, 2018 Acad, Gov/Utilities Atomic Spectroscopy

FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC)

Basel, 18 July 2018 FDA grants Breakthrough Therapy Designation for Roche’s Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC) Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab)... Read more

July 17, 2018 Acad, Gov/Utilities Atomic Spectroscopy Product Launch

Teledyne CETAC Technologies Introduces the Next Generation Homogenizing Autosampler for Oils Applications

Introducing the next generation of automation for oils, wear oils and coolants for sample introduction for ICP-OES… The ‘Oils 7400’ Homogenizing Autosampler Omaha, NE USA / July 2, 2018 – Teledyne CETAC introduces the next generation homogenizing autosampler for oils, wear oils and coolants for sample introduction for ICP-OES.  The Oils 7400 Homogenizing Autosampler is... Read more

July 9, 2018 Acad, Gov/Utilities Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Agilent and Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis

Agilent and Nanyang Technological University Singapore to Develop Novel Approaches for Water Analysis Collaboration Will Focus on Persistent and Emerging Contaminants SANTA CLARA, Calif., July 9, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it will collaborate with the Nanyang Technological University, Singapore’s (NTU Singapore’s) Nanyang Environment Water Research Institute (NEWRI) to develop novel... Read more

June 26, 2018 Acad, Gov/Utilities

FDA grants Priority Review to Roche’s baloxavir marboxil for the treatment of influenza

Basel, 26 June 2018 FDA grants Priority Review to Roche’s baloxavir marboxil for the treatment of influenza Influenza, or “flu,” represents a serious threat to public health – globally, annual epidemics result in 3 to 5 million cases of severe disease, millions of hospitalisations and up to 650,000 deaths worldwide1,2,3,4,5 If approved, baloxavir marboxil would... Read more

June 22, 2018 Acad, Gov/Utilities PR/Corporate

2018 Eppendorf Award for Young European Investigators presented to Andrea Ablasser

06/22, 2018 This year’s research prize awarded by Eppendorf AG goes to Switzerland Heidelberg/Hamburg, June 22, 2018 In 2018, the Hamburg life science company is presenting its highly prestigious research prize for the 23rd time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Andrea Ablasser, Assistant Professor at the Swiss... Read more

June 20, 2018 Acad, Gov/Utilities Lab Top-10 Life Science Tools M&A, Partnerships

Tongji University Joins MilliporeSigma’s CRISPR Core Partnership Program

With membership, Tongji University to get exclusive access to MilliporeSigma’s genome-editing technology, comprehensive technical support University joins a network of 70 CRISPR core labs around the world MilliporeSigma, a leading science and technology company and leader in genome editing, today announced a new CRISPR core partnership with Tongji University in Shanghai. Tongji University is the... Read more

June 14, 2018 Acad, Gov/Utilities Chromatography Informatics & Software Lab Top-10 M&A, Partnerships Mass Spectrometry Materials Analysis Molecular Spectroscopy

Singapore Polytechnic And Shimadzu Join Hands To Create First-Of-Its-Kind SMARTLab

June 14, 2018 Singapore, 30th day of May 2018: Shimadzu (Asia Pacific) Pte Ltd, the longest-serving global leader in providing analytical solutions, scientific equipment, testing machines, balances and medical equipment, has signed a three-year Memorandum of Understanding (MoU) with Singapore Polytechnic’s (SP) School of Chemical and Life Sciences (CLS), to create a SMART (Scalable Manageable Automated... Read more

June 13, 2018 Acad, Gov/Utilities Bio/Pharma/CRO

FDA approves Roche’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery

Basel, 13 June 2018 FDA approves Roche’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery Avastin is now approved for ten distinct uses across six different types of cancer in the United States Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug... Read more

June 13, 2018 Acad, Gov/Utilities

FDA approves Roche’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery

Basel, 13 June 2018 FDA approves Roche’s Avastin (bevacizumab) plus chemotherapy as a treatment for women with advanced ovarian cancer following initial surgery Avastin is now approved for ten distinct uses across six different types of cancer in the United States Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug... Read more